|
000
| 02648nam 2200373zi 4500 |
|---|
| 001 | 9.933621 |
|---|
| 003 | CaOODSP |
|---|
| 005 | 20240313083215 |
|---|
| 006 | m o d f |
|---|
| 007 | cr cn||||||||| |
|---|
| 008 | 240207e202002##onca ob f000 0 eng d |
|---|
| 040 | |aCaOODSP|beng|erda|cCaOODSP |
|---|
| 043 | |an-cn--- |
|---|
| 086 | 1 |aHP5-225/2020E-PDF |
|---|
| 245 | 00|aEvaluation of the Innovation Strategy 2014-15 to 2018-19 / |cprepared by the Office of Audit and Evaluation, Health Canada and the Public Health Agency of Canada. |
|---|
| 246 | 17|aEvaluation of the Innovation Strategy |
|---|
| 264 | 1|a[Ottawa] : |bHealth Canada and the Public Health Agency of Canada = Santé Canada et l'Agence de la santé publique du Canada, |cFebruary 2020. |
|---|
| 300 | |a1 online resource (vi, 42 pages) : |billustrations |
|---|
| 336 | |atext|btxt|2rdacontent |
|---|
| 337 | |acomputer|bc|2rdamedia |
|---|
| 338 | |aonline resource|bcr|2rdacarrier |
|---|
| 500 | |aCover title. |
|---|
| 500 | |aIssued also in French under title: Évaluation de la Stratégie d'innovation de 2014-2015 à 2018-2019. |
|---|
| 504 | |aIncludes bibliographical references (pages 40-42). |
|---|
| 520 | |a"In 2009-10, the Centre for Health Promotion within the Health Promotion and Chronic Disease Prevention Branch at the Public Health Agency of Canada (PHAC) launched the Innovation Strategy. The program has a current allocation of approximately $6 million annually, and was designed to test, deliver, and evaluate population health interventions to determine how they bring about change, the context in which they worked best, and for which populations. Through intersectoral project partnerships, knowledge exchange activities, and scaling up of successful interventions, the program aimed to ensure that effective and sustainable interventions would benefit as many individuals as possible within the population of interest"--Executive summary, page iii. |
|---|
| 650 | 0|aChronic diseases|zCanada|xPrevention|xEvaluation. |
|---|
| 650 | 0|aCanadians|xHealth and hygiene|xEvaluation. |
|---|
| 650 | 0|aMedical innovations|zCanada|xEvaluation. |
|---|
| 710 | 2 |aPublic Health Agency of Canada. |bOffice of Audit and Evaluation, |eissuing body. |
|---|
| 710 | 1 |aCanada. |bHealth Canada. |bOffice of Audit and Evaluation, |eissuing body. |
|---|
| 775 | 08|tÉvaluation de la Stratégie d'innovation de 2014-2015 à 2018-2019 / |w(CaOODSP)9.935296 |
|---|
| 856 | 40|qPDF|s1.76 MB|uhttps://publications.gc.ca/collections/collection_2024/aspc-phac/HP5-225-2020-eng.pdf |
|---|
| 856 | 4 |qHTML|sN/A|uhttps://www.canada.ca/en/public-health/corporate/transparency/corporate-management-reporting/evaluation/innovation-strategy.html |
|---|